Indian equities rebounded on Friday, ending a two-session losing streak as heavyweight IT stocks led gains. Nifty rose 0.35% to 24,175.65, while Sensex gained 0.43% to 77,264.51. Analysts expect consolidation amid mixed global cues and geopolitical uncertainty.
Chinese automaker BYD has experienced its first profit growth in over a year, primarily fueled by a sharp increase in export sales. This international expansion effectively balanced out the lackluster results seen domestically. In the second quarter, BYD reported a remarkable year-on-year net profit increase of 29.8 percent, although revenue faced a slight decline of 3.2 percent during the same timeframe.
Jio Platforms has received Sebi approval for its proposed Rs 37,700 crore IPO, bringing Reliance Industries’ much-awaited listing closer. The issue could value Jio at nearly Rs 9.5 trillion and become India’s largest IPO. The company plans to use Rs 27,500 crore of proceeds to repay borrowings of Reliance Jio Infocomm.
Retail investors increased holdings in 124 smallcap stocks for the fourth straight quarter. Despite subdued sector performance, nine stocks delivered 50%-150% gains alongside steadily rising retail ownership.
German bond yields moved higher as investors weighed persistent inflation risks and expectations for the European Central Bank’s interest-rate path. Short-dated yields remained under pressure, while longer-dated yields also edged up. Investors also watched French and Italian bond spreads and awaited Federal Reserve Chair Kevin Warsh’s Jackson Hole speech for clues on global monetary policy.
Sensex plunged over 2,000 points during Thursday’s closing auction session before recovering some losses, while Nifty remained comparatively stable. Market experts attributed the sharp divergence largely to thin trading volumes on BSE. The episode has renewed scrutiny of the new CAS mechanism, particularly around monthly expiry and its impact on price discovery.
SBI General Insurance reported 10.9% year-on-year GDPI growth to Rs 3,506 crore in Q1 FY27. Comprehensive income rose 17.4% to Rs 573 crore, while health, engineering and personal accident segments delivered strong growth, alongside a 2.0-times solvency ratio.
Motilal Oswal says several headwinds facing Indian equities are easing, supported by stronger earnings, positive FII flows and domestic demand. It remains Neutral on equities but Overweight on mid- and small-caps, while preferring gold over silver and accrual-focused fixed-income strategies.
Elara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its top pick for margin recovery, while Eris Lifesciences and Mankind Pharma could benefit from portfolio expansion, acquisitions and deleveraging. Elara retained a cautious view on IPCA Laboratories after its recent rally.
Google emerged as the best-performing asset in a Taurex study, gaining nearly 291% between 2020 and August 2026, while Bitcoin fell 30%. BAE Systems, gold, Apple and Microsoft also delivered gains of more than 100%. Defence stocks featured prominently among the top performers, benefiting from higher military spending, geopolitical tensions and increased global security expenditure.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.